Fiona Elwood, Ph.D., has extensive experience in neuroscience and neurodegenerative research and development, a passion for bringing relief to patients and their caregivers, and dedication to scientific excellence and exceptional teamwork. She brings deep expertise in molecular mechanisms of neurodegeneration, including in tau biology, and the use of human cell models and advanced screening approaches to support novel target identification and validation.
Fiona was most recently Interim Global Head of Neuroscience and Head of Neurodegeneration at Novartis Institute for Biomedical Research. Before moving to Novartis, she spent nearly 10 years at Merck Research Laboratories in positions of increasing responsibility.
Fiona received her doctorate in Neuroscience from the University of London, United Kingdom, and completed her postdoctoral work in Neuroscience at Stanford University.